Pando Software Begins Pre-Registration of Three New P2E Pandonia Universes
The new P2E Pandonia Universe starts pre-registration ahead of its simultaneous worldwide release. The three Pandonia Universes include ‘Pandonia Arena,’ ‘Guardians of Pandonia,’ and ‘Dragons of Pandonia.’ Pre-registration is available now on https://pandonia.co.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220426006357/en/
Three new P2E Pandonia Universes have started pre-registration ahead of their worldwide release. The three Pandonia Universes include ‘Pandonia Arena,’ ‘Guardians of Pandonia,’ and ‘Dragons of Pandonia.’ Pre-registration is available now on the official website. (Graphic: Business Wire)
‘Pandonia Arena’ with unique heroes
‘Pandonia Arena’ was issued as non-fungible tokens (NFT) for heroes with distinctive visuals and unique skills. The control method that allows anyone to play easily, such as battle royale mode, big boss mode, and crown mode, is a huge advantage. The global No.1 Arcade NFT-based P2E game ‘Pandonia Arena’ will be released in May.
New collectible RPG, P2E game ‘Guardians of Pandonia’
‘Guardians of Pandonia’ is a mobile collectible RPG where you can create your own team with up to six characters and enjoy adventures, raids, and PvP content. In particular, there are high expectations for this new collectible P2E game in Japan, so it is planned to be released in June.
MMORPG 'Dragons of Pandonia,' a story created with a variety of dragons
‘Dragons of Pandonia’ is an MMORPG focused on dragons. It is the P2E-based MMORPG where users write their own huge and powerful stories relying on five different occupation types and various dragons. Development is underway aiming at a global launch in July.
Special benefits for pre-registrants of the three Pandonia Universes
For pre-registered users, Pando Software has announced that it will provide game-related privileges along with an airdrop event in which 10,000 mPANDO will be drawn and distributed, fitting the game's official release date.
In the three new Pandonia Universes, users can acquire mPANDO through gameplay as well as through other games currently being serviced by Pando Software. mPANDO is a MainNet coin and is designed to be used for various in-game applications.
Starting with the ‘Legend of Pandonia’ as its first P2E project in 2022, Pando Software has continued with the ‘I Love Pandonia’ release to the global market.
The detailed schedule and news about the three Pandonia Universes can be checked on the official website (https://pandonia.co).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426006357/en/
Contact information
Pando Software Inc
Lucia Tanti
+82-70-5100-0815
pr@pandosoft.co.kr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2026 Japan Prize: Two U.S. Scientists and One Japanese Scientist Awarded26.1.2026 16:00:00 EET | Press release
The Japan Prize Foundation announced the winners of the 2026 Japan Prize at 1:00 p.m. on 21 January 2026. Prof. Cynthia Dwork (USA) has been awarded the Japan Prize in the field of Electronics, Information, and Communication. Prof. Shizuo Akira (Japan) and Prof. Zhijian "James" Chen (USA) have been awarded the Japan Prize in the field of Life Sciences. For this year’s Japan Prize, Prof. Dwork is being recognized for her Contribution to leading research for building an ethical digital society, including differential privacy and fairness. Prof. Akira and Prof. Chen are being recognized for their Discovery of the nucleic acid sensing mechanism by the innate immune system. For the 2026 Japan Prize, the Foundation asked approximately 16,000 prominent scientists and engineers from around the world to nominate researchers working in this year’s fields. We received 107 nominations for the field of Electronics, Information, and Communication, and 185 nominations for the field of Life Sciences.
Uzbekistan, the Engine of Central Asia: GDP Above USD 145 Billion and Exports Rising to USD 33.4 Billion – Embassy of the Republic of Uzbekistan in Italy26.1.2026 15:31:00 EET | Press release
With a GDP exceeding USD 145 billion, exports of USD 33.4 billion up 23 percent, and gold reserves surpassing USD 60 billion, Uzbekistan enters 2026 with solid and steadily strengthening macroeconomic indicators. The Embassy of the Republic of Uzbekistan in Italy claims that the climate of confidence, reaffirmed in the State of the Nation Address delivered on 26 December by President Shavkat Mirziyoyev, is reflected in international trade data: total foreign investment has reached USD 43.1 billion, equal to 31.9 percent of GDP. This trajectory has also contributed to an improvement in the country’s sovereign rating, upgraded to BB by the leading international rating agencies. For the current year, the Government forecasts economic growth of 6.6 percent, with GDP estimated at USD 167 billion. A total of 782 new industrial and infrastructure projects will be launched, with an overall value of USD 52 billion, including 228 large production facilities as early as next year. The focus will
Novaliq Receives FDA IND Clearance to Advance NOV05 in a Phase II Clinical Trial in Non-infectious Anterior Uveitis26.1.2026 15:00:00 EET | Press release
Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for NOV05, the company’s first IND for treating inner-eye diseases. NOV05, tacrolimus ophthalmic solution in EyeSol®, is a unique, steroid-free topical anti-inflammatory treatment. The IND clearance enables initiation of the EYETAC Phase II clinical trial in patients with non-infectious anterior uveitis (NIAU). Anterior uveitis is an inflammation of the inner eye including the iris and ciliary body, that typically causes a red, painful, light‑sensitive eye and can lead to vision loss if not treated promptly. NIAU represents 67-90% of uveitis cases in the developed world.1 To treat uveitis a drug must reach the uveal tract inside the eye. Current treatment choices are limited to corticosteroid eye drops and, if insuffic
Lucend, Formerly Coolgradient, Raises $3.3M to Bring Transparent AI to Data Centers to Increase Uptime and Reliability While Maximizing Efficiency26.1.2026 15:00:00 EET | Press release
Lucend today announced that it is bringing its transparent data center optimization to the U.S. market, helping enterprises illuminate complex operational environments and empowering data center operators, innovation officers, and sustainability officers with the intelligence they need to act with trust, accuracy, and confidence. Lucend’s Transparent AI platform connects to existing infrastructure, no new hardware required, to transform static systems into adaptive, self-learning environments. The software takes existing sensor data to see connections across 300 billion sensor readings. Lucend’s AI analyzes billions of data points daily and provides prescriptive recommendations. The intelligence that Lucend’s platform delivers “shows its work,” empowering operators and delivering verifiable impact across enterprise environments that demand both performance and trust. “Lucend’s Transparent AI platform analyzes billions of data points daily and provides prescriptive recommendations that
IQM Quantum Computers Appoints Jan Goetz as Sole CEO to Lead Next Phase of Global Growth26.1.2026 11:15:00 EET | Press release
IQM Quantum Computers, a global leader in full-stack superconducting quantum computers, today announced a transition from its Co-CEO structure to a single Chief Executive Officer model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126737805/en/ From left to right: Jan Goetz (Co-founder & CEO) and Søren Hein (Chief Operating Officer and Deputy CEO) Co-founder and current Co-CEO Dr Jan Goetz becomes sole CEO effective since January 1st, following a resolution passed by the IQM board. In addition, Dr Søren Hein has been appointed Chief Operating Officer and Deputy CEO. As part of the transition, Mikko Välimäki steps down from his commercial role following a successful tenure as Co-CEO. He will continue to support the company as an advisor until 31 March 2026 to ensure continuity and a smooth transition. “Our dual CEO approach has served IQM well over the past two years, and I want to thank Mikko Välimäki for his significan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom